Alnylam Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US02043Q1076

SecurityALNY / Alnylam Pharmaceuticals, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership1,059,062 shares
Latest Disclosed Value $ 350,411,844
D. E. Shaw & Co., Inc. ownership in ALNY / Alnylam Pharmaceuticals, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 1,059,062 shares of Alnylam Pharmaceuticals, Inc. (US:ALNY) valued at $350,411,844 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 444,493 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 138.26% during the quarter. The current value of the position is $309,860,360 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (ALNY) in the form of stock options. The firm currently holds call options representing 408,800 of underlying shares valued at $135,259,656 USD and put options representing 6,500 of underlying shares valued at $2,150,655 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ALNY / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,059,062 614,569 138.26 350,412 98.25 0.1547
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 444,493 245,076 122.90 176,753 94.37 0.0969
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 199,417 91,141 84.17 90,934 157.55 0.0513
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 108,276 -181,586 -62.65 35,308 -54.89 0.0250
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 289,862 -73,223 -20.17 78,269 -8.39 0.0697
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 363,085 30,780 9.26 85,438 -6.52 0.0627
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 332,305 52,907 18.94 91,394 34.61 0.0785
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 279,398 176,011 170.24 67,894 339.41 0.0635
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 103,387 7,843 8.21 15,451 -15.51 0.0132
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 95,544 -108,548 -53.19 18,288 -49.40 0.0160
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 204,092 -44,180 -17.79 36,145 -23.35 0.0377
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 248,272 16,927 7.32 47,157 1.75 0.0482
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 231,345 54,929 31.14 46,343 10.54 0.0496
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 176,416 25,272 16.72 41,925 38.58 0.0463
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 151,144 15,221 11.20 30,253 52.61 0.0361
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 135,923 121,040 813.28 19,824 715.80 0.0232
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 14,883 -31,457 -67.88 2,430 -69.08 0.0023
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 46,340 13,277 40.16 7,858 25.87 0.0065
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 33,063 -3,345 -9.19 6,243 1.15 0.0056
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 36,408 -41,495 -53.26 6,172 -43.89 0.0053
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 77,903 13,402 20.78 10,999 31.21 0.0106
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 64,501 -105,737 -62.11 8,383 -66.18 0.0075
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 170,238 56,351 49.48 24,787 46.95 0.0254
2020-08-14 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 113,887 -116,666 -50.60 16,868 -32.79 0.0201
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 230,553 211,925 1,137.67 25,096 1,069.98 0.0392
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 18,628 -8,169 -30.48 2,145 -0.46 0.0025
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 26,797 13,040 94.79 2,155 115.93 0.0027
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 13,757 2,543 22.68 998 -4.77 0.0012
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,214 -25,604 -69.54 1,048 -60.95 0.0014
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 36,818 28,080 321.36 2,684 250.85 0.0037
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,738 -74,873 -89.55 765 -90.71 0.0009
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 83,611 -187,450 -69.15 8,235 -74.49 0.0107
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 271,061 -1,659 -0.61 32,283 -6.83 0.0439
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 272,720 -709,734 -72.24 34,649 -69.98 0.0477
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 982,454 248,804 33.91 115,429 97.26 0.1773
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 733,650 238,256 48.09 58,516 130.48 0.0968
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 495,394 279,968 129.96 25,389 214.80 0.0446
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 215,426 190,304 757.52 8,065 373.58 0.0137
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 25,122 -14,630 -36.80 1,703 -22.80 0.0030
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 39,752 -155,292 -79.62 2,206 -81.98 0.0041
2016-05-16 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 195,044 113,932 140.46 12,243 60.33 0.0220
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 81,112 43,599 116.22 7,636 153.27 0.0114
2015-11-16 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 37,513 -166,514 -81.61 3,015 -87.67 0.0044
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 204,027 -63,585 -23.76 24,457 -12.48 0.0364
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 267,612 76,353 39.92 27,944 50.63 0.0428
2015-02-17 2014-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 191,259 177,116 1,252.32 18,552 1,578.91 0.0239
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 14,143 7,722 120.26 1,105 172.17 0.0014
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,421 -68,712 -91.45 406 -91.95 0.0006
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 75,133 68,233 988.88 5,044 1,036.04 0.0072
2014-02-14 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,900 3,601 109.15 444 110.43 0.0006
2013-11-20 2013-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 3,299 -215,789 -98.49 211 -96.89 0.0003
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,299 211
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 219,088 219,088 6,794 0.0128
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 408,800 2.92 135,260 -14.36 n/a n/a n/a
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 397,200 1,145.14 157,947 985.84 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 31,900 1,893.75 14,546 2,691.94 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 1,600 0.00 522 20.60 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 1,600 -93.22 432 -92.22 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 23,600 0.00 5,553 -14.44 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 23,600 0.00 6,491 13.18 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 23,600 -77.80 5,735 -63.91 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 106,300 58.66 15,887 23.88 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 67,000 18.37 12,824 27.95 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 56,600 30.41 10,024 21.59 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 43,400 0.00 8,243 -5.18 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 43,400 -18.73 8,694 -31.50 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 53,400 33.50 12,691 58.51 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 40,000 0.00 8,006 37.23 n/a n/a n/a
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 40,000 33.33 5,834 19.09 n/a n/a n/a
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 30,000 0.00 4,899 -3.70 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 30,000 5,087 n/a n/a n/a
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 21,000 -30.00 3,560 -15.96 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 30,000 -43.18 4,236 -38.27 n/a n/a n/a
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 52,800 0.00 6,862 -10.74 n/a n/a n/a
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 52,800 -27.47 7,688 -28.70 n/a n/a n/a
2020-08-14 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 72,800 31.17 10,782 78.48 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 55,500 9.90 6,041 3.87 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 50,500 44.29 5,816 106.61 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 35,000 0.00 2,815 10.83 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 35,000 -36.36 2,540 -50.58 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 55,000 7.84 5,140 38.25 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 51,000 1.19 3,718 -15.71 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 50,400 236.00 4,411 198.65 n/a n/a n/a
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 15,000 0.00 1,477 -17.35 n/a n/a n/a
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 15,000 50.00 1,787 40.60 n/a n/a n/a
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 10,000 0.00 1,271 8.17 n/a n/a n/a
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 10,000 0.00 1,175 47.24 n/a n/a n/a
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 10,000 0.00 798 -32.09 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 10,000 13.64 1,044 76.65 n/a n/a n/a
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 8,800 0.00 591 4.42 n/a n/a n/a
2014-02-14 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 8,800 566 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 6,500 261.11 2,151 200.70 n/a n/a n/a
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 1,800 100.00 716 74.39 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 900 410 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 4,600 0.00 1,082 -14.47 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 4,600 0.00 1,265 13.25 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 4,600 -89.23 1,118 -82.49 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 42,700 828.26 6,382 625.11 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 4,600 880 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 25,000 0.00 5,941 18.73 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 25,000 0.00 5,004 37.25 n/a n/a n/a
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 25,000 0.00 3,646 -10.68 n/a n/a n/a
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 25,000 0.00 4,082 -3.73 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 25,000 108.33 4,240 87.11 n/a n/a n/a
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 12,000 0.00 2,266 11.41 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 12,000 2,034 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 44,800 0.00 5,823 -10.73 n/a n/a n/a
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 44,800 0.00 6,523 -1.69 n/a n/a n/a
2020-08-14 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 44,800 -25.33 6,635 1.59 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 60,000 310.96 6,531 288.52 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 14,600 -45.11 1,681 -21.41 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 26,600 -22.45 2,139 -14.06 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 34,300 4.26 2,489 -19.06 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 32,900 -28.94 3,075 -8.92 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 46,300 -11.64 3,376 -26.38 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 52,400 355.65 4,586 304.77 n/a n/a n/a
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 11,500 -28.12 1,133 -40.56 n/a n/a n/a
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 16,000 16.79 1,906 9.48 n/a n/a n/a
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 13,700 41.24 1,741 52.72 n/a n/a n/a
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 9,700 0.00 1,140 47.29 n/a n/a n/a
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 9,700 0.00 774 55.73 n/a n/a n/a
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 9,700 0.00 497 36.91 n/a n/a n/a
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 9,700 -51.50 363 -73.23 n/a n/a n/a
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 20,000 0.00 1,356 22.16 n/a n/a n/a
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 20,000 0.00 1,110 -11.55 n/a n/a n/a
2016-05-16 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 20,000 0.00 1,255 13.06 n/a n/a n/a
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-16 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 10,000 -66.67 804 -77.64 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 49.25 3,596 166.37 n/a n/a n/a
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 20,100 0.00 1,350 4.41 n/a n/a n/a
2014-02-14 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 20,100 1,293 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.